Spots Global Cancer Trial Database for vpm1002bc
Every month we try and update this database with for vpm1002bc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC | NCT04630730 | Bladder Cancer | Recombinant int... Atezolizumab Cisplatin Gemcitabine | 18 Years - | Swiss Group for Clinical Cancer Research | |
VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer | NCT02371447 | Bladder Cancer | VPM1002BC | 18 Years - 85 Years | Swiss Group for Clinical Cancer Research | |
Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC | NCT04630730 | Bladder Cancer | Recombinant int... Atezolizumab Cisplatin Gemcitabine | 18 Years - | Swiss Group for Clinical Cancer Research |